The current institutional shareholding score of NewAmsterdam Pharma Company NV is 10.00, ranking 1 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 110.09%, representing a quarter-over-quarter increase of 5.56%. The largest institutional shareholder is Andreas Halvorsen, holding a total of 3.68M shares, representing 3.60% of shares outstanding, with 0.12% increase in holdings.